Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov;52(11):2260-2271.
doi: 10.18502/ijph.v52i11.14026.

Diagnostic and Prognostic Value of miR-93 in Prostate Cancer: A Meta-Analysis and Bioinformatics Analysis

Affiliations
Review

Diagnostic and Prognostic Value of miR-93 in Prostate Cancer: A Meta-Analysis and Bioinformatics Analysis

Hassane Gazzaz et al. Iran J Public Health. 2023 Nov.

Abstract

Background: Accurate and non-invasive diagnostic and prognostic markers are necessary to improve patient outcomes. MicroRNAs have been proposed as relatively non-invasive and pertinent biomarkers. miR-93 has been studied for its potential as a diagnostic and prognostic marker in prostate cancer (PCa), but findings from individual studies are inconsistent. We conducted a meta-analysis of its overall differential expression in 13 PCa studies and a bioinformatics analysis to provide a comprehensive appraisal of its diagnostic and prognostic role.

Methods: We searched all published papers on miR-93 expression in PCa up to Nov 30, 2022 using PubMed, Science Direct, Web of Science, Cochrane Central Register of Controlled Trials databases. We used RevMan software to Meta-analyze the included literature. A bioinformatics analysis of genes and pathways that might be target to the effect of the mature miR-93-5p was carried out.

Results: The pooled standardized mean difference (SMD) of miR-93 expression in PCa, its area under the curve (AUC) and hazard ratio (HR) were 1.26, 95% CI [-0.34-2.86], 0.84, 95% CI [0.76 -0.93] and 1.67, 95% CI [0.98, 2.84] respectively. Bioinformatics analysis revealed that mature miR-93-5p may regulate genes such as SMAD1, SMAD7 and MAPK and the PI3K-Akt signaling pathways.

Conclusion: miR-93 has significant diagnostic and prognostic value in PCa. These findings highlight the potential of miR-93 as a non-invasive biomarker for PCa and may contribute to earlier detection and prognostic assessment. The target genes and signaling pathways regulated by miR-93 may provide insights into the underlying molecular mechanisms of PCa.

Keywords: Bioinformatics; Expression; Meta-analysis; Prostate; miR-93.

PubMed Disclaimer

Figures

Fig. 1:
Fig. 1:
A PRISMA flow diagram of study eligibility and ineligibility process
Fig. 2:
Fig. 2:
Random-effects SMD for the association of miR-93 expression level and PCa
Fig. 3:
Fig. 3:
Forest plot illustrating relationship between miR-93 levels and overall survival (OS) in PCa
Fig. 4:
Fig. 4:
Funnel plot of A) standardized mean difference, B) hazard ratio
Fig. 5:
Fig. 5:
Go enrichment, A) biological process B) cellular component C) molecular function and D) KEGG
Fig. 6:
Fig. 6:
Validation of the miR-93-5p Target Genes, A) SMAD1 expression, B) KM of SMAD1, C) Spearman correlation between SMAD1 and miR-93-5p, D) S:MAD7 expression, E) KM of SMAD7, F) Spearman correlation between SMAD7 and miR-93-5p, G) BMPR2 expression, H) KM of BMPR2, I) Spearman correlation between BMPR2 and miR-93-5p, KM: Kaplan Meier

References

    1. Ferlay J, Colombet M, Soerjomataram I, et al. (2021). Cancer statistics for the year 2020: An overview. Int J Cancer, 10.1002/ijc.33588. - DOI - PubMed
    1. Siegel RL, Miller KD, Fuchs HE, Jemal A. (2021). Cancer Statistics, CA Cancer J Clin, 2021 71(1):7–33. - PubMed
    1. Gasinska A, Jaszczynski J, Rychlik U, Łuczynska E, Pogodzinski M, Palaczynski M. (2020). Prognostic Significance of Serum PSA Level and Telomerase, VEGF and GLUT-1 Protein Expression for the Biochemical Recurrence in Prostate Cancer Patients after Radical Prostatectomy. Pathol Oncol Res, 26(2):1049–56. - PMC - PubMed
    1. Chen D, Cabay RJ, Jin Y, Wang A, Lu Y, Shah-Khan M, et al. (2013). MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas. J Oral Maxillofac Res, 4(1): e2. - PMC - PubMed
    1. Arantes LMRB, Laus AC, Melendez ME, et al. (2017). MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol. Oncotarget, 8(6):9911–21. - PMC - PubMed

LinkOut - more resources